BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2020. The put-call ratio across all filers is 4.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,099,319 | -12.6% | 121,452 | +9.9% | 0.01% | 0.0% |
Q2 2023 | $6,981,514 | -21.7% | 110,467 | -44.3% | 0.01% | -28.6% |
Q1 2023 | $8,921,832 | +48.3% | 198,307 | +44.4% | 0.01% | +40.0% |
Q4 2022 | $6,015,945 | -48.3% | 137,319 | -22.2% | 0.01% | -44.4% |
Q3 2022 | $11,635,000 | +80.1% | 176,576 | +38.1% | 0.01% | +80.0% |
Q2 2022 | $6,460,000 | +340.1% | 127,904 | +456.5% | 0.01% | +400.0% |
Q1 2022 | $1,468,000 | -78.3% | 22,982 | -63.6% | 0.00% | -75.0% |
Q4 2021 | $6,765,000 | +11.3% | 63,161 | +6.9% | 0.00% | 0.0% |
Q3 2021 | $6,077,000 | +10.7% | 59,105 | -5.3% | 0.00% | +33.3% |
Q2 2021 | $5,489,000 | +27.4% | 62,398 | +40.7% | 0.00% | 0.0% |
Q1 2021 | $4,310,000 | +168.9% | 44,334 | +210.0% | 0.00% | +200.0% |
Q4 2020 | $1,603,000 | +161.1% | 14,302 | +116.1% | 0.00% | – |
Q3 2020 | $614,000 | -78.0% | 6,618 | -81.5% | 0.00% | -100.0% |
Q2 2020 | $2,793,000 | +16.8% | 35,806 | -12.4% | 0.00% | 0.0% |
Q1 2020 | $2,391,000 | +33.4% | 40,882 | +82.8% | 0.00% | +100.0% |
Q4 2019 | $1,793,000 | -10.8% | 22,369 | -18.2% | 0.00% | -50.0% |
Q3 2019 | $2,010,000 | -70.9% | 27,361 | -62.7% | 0.00% | -66.7% |
Q2 2019 | $6,914,000 | +223.1% | 73,287 | +174.2% | 0.01% | +200.0% |
Q1 2019 | $2,140,000 | -72.0% | 26,731 | -81.1% | 0.00% | -75.0% |
Q4 2018 | $7,633,000 | -46.2% | 141,594 | -22.1% | 0.01% | -38.5% |
Q3 2018 | $14,181,000 | +15.7% | 181,670 | -5.9% | 0.01% | +18.2% |
Q2 2018 | $12,258,000 | +21405.3% | 193,104 | +30747.3% | 0.01% | – |
Q1 2018 | $57,000 | +111.1% | 626 | +72.5% | 0.00% | – |
Q4 2017 | $27,000 | -98.7% | 363 | -98.8% | 0.00% | -100.0% |
Q3 2017 | $2,048,000 | +12.5% | 29,395 | -18.2% | 0.00% | 0.0% |
Q2 2017 | $1,821,000 | +239.7% | 35,948 | +168.0% | 0.00% | – |
Q1 2017 | $536,000 | -71.0% | 13,412 | -79.6% | 0.00% | -100.0% |
Q4 2016 | $1,847,000 | +872.1% | 65,854 | +927.2% | 0.00% | – |
Q3 2016 | $190,000 | +48.4% | 6,411 | +1.5% | 0.00% | – |
Q2 2016 | $128,000 | -37.6% | 6,318 | -44.3% | 0.00% | – |
Q1 2016 | $205,000 | -90.9% | 11,351 | -86.7% | 0.00% | -100.0% |
Q4 2015 | $2,243,000 | +37.4% | 85,163 | +11.3% | 0.00% | 0.0% |
Q3 2015 | $1,633,000 | +40725.0% | 76,495 | +52655.2% | 0.00% | – |
Q2 2015 | $4,000 | – | 145 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
SIB LLC | 65,151 | $6,335,000 | 3.72% |
CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |